Pemphigus is a life threatening autoimmune epidermal blistering disease involving skin and mucous membranes. Pemphigus usually affects middle age men and women involving oral mucosa first and then spreading on the skin. It is caused by the presence of autoantibodies (IgG and less frequently by IgA) directed against desmogleins, and/or other glycoproteins that plays a critical role in cell-cell attachment. Upon a predisposing genetic background, different agents have been shown to act as triggers for the pathogenesis of pemphigus. This guideline for the diagnosis and treatment of pemphigus has been developed by an Italian group of experts taking in account the Italian legislation and local pharmacological governance. Guidelines are adapted from the original article under the guidance of the European Dermatology Forum in collaboration with the European Academy of Dermatology and Venereology. It summarizes evidence-based and expert-based recommendations (S2 level).

Feliciani, C., Cozzani, E., Marzano, A.v., Caproni, M., Di Zenzo, G., Calzavara-Pinton, P., et al. (2018). Italian Guidelines in Pemphigus - adapted from the European Dermatology Forum (EDF) and European Academy of Dermatology and Venerology (EADV). GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 153(5), 599-608 [10.23736/S0392-0488.18.06073-X].

Italian Guidelines in Pemphigus - adapted from the European Dermatology Forum (EDF) and European Academy of Dermatology and Venerology (EADV)

Talamonti Marina
2018-10-01

Abstract

Pemphigus is a life threatening autoimmune epidermal blistering disease involving skin and mucous membranes. Pemphigus usually affects middle age men and women involving oral mucosa first and then spreading on the skin. It is caused by the presence of autoantibodies (IgG and less frequently by IgA) directed against desmogleins, and/or other glycoproteins that plays a critical role in cell-cell attachment. Upon a predisposing genetic background, different agents have been shown to act as triggers for the pathogenesis of pemphigus. This guideline for the diagnosis and treatment of pemphigus has been developed by an Italian group of experts taking in account the Italian legislation and local pharmacological governance. Guidelines are adapted from the original article under the guidance of the European Dermatology Forum in collaboration with the European Academy of Dermatology and Venereology. It summarizes evidence-based and expert-based recommendations (S2 level).
ott-2018
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/35 - MALATTIE CUTANEE E VENEREE
English
Con Impact Factor ISI
Autoantibodies; Evidence-Based Medicine; Female; Humans; Italy; Male; Pemphigus; Skin
www.minervamedica.it/en/journals/dermatologia-venereologia/article.php?cod=R23Y2018N05A0599
Feliciani, C., Cozzani, E., Marzano, A.v., Caproni, M., Di Zenzo, G., Calzavara-Pinton, P., et al. (2018). Italian Guidelines in Pemphigus - adapted from the European Dermatology Forum (EDF) and European Academy of Dermatology and Venerology (EADV). GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 153(5), 599-608 [10.23736/S0392-0488.18.06073-X].
Feliciani, C; Cozzani, E; Marzano, Av; Caproni, M; Di Zenzo, G; Calzavara-Pinton, P; Talamonti, M
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
feliciani2018.pdf

solo utenti autorizzati

Licenza: Non specificato
Dimensione 405.12 kB
Formato Adobe PDF
405.12 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/244278
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 11
social impact